Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Diseaseopen access
- Authors
- Yun, Chul Won; Lee, Sang Hun
- Issue Date
- 2-Feb-2019
- Publisher
- Multidisciplinary Digital Publishing Institute (MDPI)
- Keywords
- mesenchymal stem cells; cardiovascular disease; exosome; natural products
- Citation
- International Journal of Molecular Sciences, v.20, no.4
- Journal Title
- International Journal of Molecular Sciences
- Volume
- 20
- Number
- 4
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/4728
- DOI
- 10.3390/ijms20040982
- ISSN
- 1661-6596
1422-0067
- Abstract
- Cardiovascular disease usually triggers coronary heart disease, stroke, and ischemic diseases, thus promoting the development of functional failure. Mesenchymal stem cells (MSCs) are cells that can be isolated from various human tissues, with multipotent and immunomodulatory characteristics to help damaged tissue repair and avoidance of immune responses. Much research has proved the feasibility, safety, and efficiency of MSC-based therapy for cardiovascular disease. Despite the fact that the precise mechanism of MSCs remains unclear, their therapeutic capability to treat ischemic diseases has been tested in phase I/II clinical trials. MSCs have the potential to become an effective therapeutic strategy for the treatment of ischemic and non-ischemic cardiovascular disorders. The molecular mechanism underlying the efficacy of MSCs in promoting engraftment and accelerating the functional recovery of injury sites is still unclear. It is hypothesized that the mechanisms of paracrine effects for the cardiac repair, optimization of the niche for cell survival, and cardiac remodeling by inflammatory control are involved in the interaction between MSCs and the damaged myocardial environment. This review focuses on recent experimental and clinical findings related to cardiovascular disease. We focus on MSCs, highlighting their roles in cardiovascular disease repair, differentiation, and MSC niche, and discuss their therapeutic efficacy and the current status of MSC-based cardiovascular disease therapies.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Biochemistry > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.